Feature article
Multidrug resistance from the clinical point of view

https://doi.org/10.1016/0277-5379(91)90036-DGet rights and content

First page preview

First page preview
Click to open first page preview

References (60)

  • JL Biedler et al.

    Cellular resistance to actinomycin D in chinese hamster cells in vitro: cross resistance, radioautographic and cytogenetic studies

    Cancer Res

    (1970)
  • K Danø

    Cross resistance between vinca-alkaloids and anthracyclines in Ehrlich ascites tumor cells in vivo

    Cancer Chemother Rep

    (1972)
  • RL Juliano et al.

    A surface glycoprotein modulating drug permeability in chinese ovary cell mutants

    Biochim Biophys Acta

    (1976)
  • AH Schinkel et al.

    Characterisation of the human MDR 3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies

    Cancer Res

    (1991)
  • CP Huang Yang et al.

    Progesterone interacts with P-glycoprotein in multidrug resistant cells and in the endometrium of the gravid uterus

    J Biol Chem

    (1989)
  • JJ Arceci et al.

    Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus

    Mol Reprod Dev

    (1990)
  • L Goldstein et al.

    Expression of a multidrug resistance gene in human tumors

    J Natl Cancer Inst

    (1989)
  • J Holmes et al.

    Multidrug resistance in haematopoietic cell lines, myelodysplastic syndromes and acute myelocytic leukaemia

    Br J Haematol

    (1989)
  • H Sato et al.

    Expression of the multidrug resistance gene in myeloid leukemias

    Leuk Res

    (1990)
  • H Herweyer et al.

    Expression of mdr1 and mdr3 multidrug resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporin-A

    J Natl Cancer Inst

    (1990)
  • R Pirker et al.

    MDR1 gene expression and treatment outcome in acute myeloid leukemia

    J Natl Cancer Inst

    (1991)
  • ED Ball et al.

    Correlation of CD34 and multidrug resistance P-170 with FAB and cytogenetics but not with prognosis in acute myeloid luekemia (AML)

    Blood

    (1990)
  • KE Noonan et al.

    Quantitative analysis of mdr1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction

  • P Musto et al.

    High risk of early relapse for leukemic patients with presence of multidrug associated P-glycoprotein positive cells in complete remission

    Br J Hematol

    (1991)
  • R Pirker et al.

    Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia

    Cancer Commun

    (1989)
  • S Kato et al.

    Overexpression of P-glycoprotein in adult T-cell leukemia

    Lancet

    (1991)
  • CM Kuiper et al.

    Drug transport variants without P-glycoprotein overexpression from a squamous lung cancer cell line after selection with doxorubicin

    J Cell Pharmacol

    (1990)
  • F Baas et al.

    Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line

    Cancer Res

    (1990)
  • K Nooter et al.

    Overexpression of the mdr1-gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A

    Int J Cancer

    (1990)
  • K Nooter et al.

    Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation

    Int J Cancer

    (1990)
  • Cited by (49)

    • Effect of prednisolone pre-treatment on cat lymphoma cell sensitivity towards chemotherapeutic drugs

      2021, Research in Veterinary Science
      Citation Excerpt :

      However, it is of vast importance for the clinical decision making to answer the question whether or not glucocorticoid pre-treatment significantly influences the effectiveness of chemotherapy in feline tumor patients. Among the aspects influencing the therapeutic outcome, drug resistance (both intrinsic and acquired) is a common phenomenon and the most common cause of treatment failure (van Kalken et al., 1991). Overexpression of ATP binding cassette transporters (ABC superfamily proteins), which efflux a wide spectrum of anticancer drugs against their concentration gradient using ATP-driven energy, is the most important mechanism of multidrug resistance (Bergman, 2002; Sodani et al., 2012).

    • Antisense- and antigene-based drug design strategies in oncology

      1998, Advances in DNA Sequence-Specific Agents
    View all citing articles on Scopus
    View full text